K-ras is an essential gene in the mouse with partial functional overlap with N-ras

Genes and Development

Volumn 11, Issue 19, 1997, Pages 2468-2481

  Johnson, Leisa ^a   Greenbaum, Doron ^a   Cichowski, Karen ^a   Mercer, Kim ^a,b   Murphy, Elizabeth ^a,c   Schmitt, Eric ^a   Bronson, Roderick T ^d   Umanoff, Heywood ^e   Edelmann, Windfried ^e   Kucherlapati, Raju ^e   Jacks, Tyler ^a,b  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^b HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Embryogenesis; Hematopoiesis; K Ras; Knockout mouse; N Ras; Oncogene

Indexed keywords

RAS PROTEIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; EMBRYO; EMBRYO DEVELOPMENT; FEMALE; GENE MUTATION; GENE TARGETING; HEMATOPOIESIS; MALE; MOUSE; NONHUMAN; ONCOGENE K RAS; ONCOGENE N RAS; PRIORITY JOURNAL;

EID: 0345135149     PISSN: 08909369     EISSN: None     Source Type: Journal    
DOI: 10.1101/gad.11.19.2468     Document Type: Article

References (55)

1. Barbacid, M. 1987. ras genes. Annu. Rev. Biochem. 56: 779-827.
2. Bos, J.L. 1988. The ras gene family and human carcinogenesis. Mutat. Res. 195: 255-271.
3. _. 1989. ras oncogenes in human cancer: A review [published erratum appears in Cancer Res 1990 Feb 15; 50 (4): 1352]. Cancer Res. 49: 4682-4689.
4. Bourne, H.R., D.A. Sanders, and F. McCormick. 1990. The GT-Pase superfamily: A conserved switch for diverse cell functions. Nature 348: 125-132.
5. Bradley, A. 1987. Production and analysis of Chimeric mice. In Teratocarcinomas and embryonic stem cells: A practical approach (ed. E.J. Robertson), pp. 113-152. IRL Press, Oxford, UK.
6. Cai, H., J. Szeberenyi, and G.M. Cooper. 1990. Effect of a dominant inhibitory Ha-ras mutation on mitogenic signal transduction in NIH 3T3 cells. Mol. Cell. Biol. 10: 5314-5323.
7. Capon, D.J., P.H. Seeburg, J.P. McGrath, J.S. Hayflick, U. Edman, A.D. Levinson, and D.V. Goeddel. 1983. Activation of Ki-ras2 gene in human colon and lung carcinomas by two different point mutations. Nature 304: 507-513.
8. Chesa, P.G., W.J. Rettig, M.R. Melamed, L.J. Old, and H.L. Niman. 1987. Expression of p21ras in normal and malignant human tissues: Lack of association with proliferation and malignancy. Proc. Natl. Acad. Sci. 84: 3234-3238.
9. Daum, G., T.I. Eisenmann, H.W. Fries, J. Troppmair, and U.R. Rapp. 1994. The ins and outs of Raf kinases. Trends Biochem. Sci 19: 474-480.
10. Davis, R.J. 1994. MAPKs: New JNK expands the group. Trends Biochem. Sci. 19: 470-473.
11. Duffy, J.B. and N. Perrimon. 1996. Recent advances in understanding signal transduction pathways in worms and flies. Curr. Opin. Cell Biol. 8: 231-238.
12. Dzierzak, E. and A. Medvinsky. 1995. Mouse embryonic hematopoiesis. Trends Genet. 11: 359-366.
13. Ellis, R.W., D. Defeo, T.Y. Shih, M.A. Gonda, H.A. Young, N. Tsuchida, D.R. Lowy, and E.M. Scolnick. 1981. The p21 src genes of Harvey and Kirsten sarcoma viruses originate from divergent members of a family of normal vertebrate genes. Nature 292: 506-511.
14. Furth, M.E., T.H. Aldrich, and C.C. Cordon. 1987. Expression of ras proto-oncogene proteins in normal human tissues. Oncogene 1: 47-58.
15. George, D.L., A.F. Scott, S. Trusko, B. Glick, E. Ford, and D.J. Dorney. 1985. Structure and expression of amplified cKi-ras gene sequences in Y1 mouse adrenal tumor cells. EMBO J. 4: 1199-1203.
16. Gibbs, J.B., A. Oliff, and N.E. Kohl. 1994. Farnesyltransferase inhibitors: Ras research yields a potential cancer therapeutic. Cell 77: 175-178.
17. Glomset, J.A. and C.C. Farnsworth. 1994. Role of protein modification reactions in programming interactions between ras-related GTPases and cell membranes. Annu. Rev. Cell Biol. 10: 181-205.
18. Gossler, A., T. Doetschman, R. Korn, E. Serfling, and R. Kemler. 1986. Transgenesis by means of blastocyst-derived embryonic stem cell lines. Proc. Natl. Acad. Sci. 83: 9065-9069.
19. Hall, A. 1994. Small GTP-binding proteins and the regulation of the actin cytoskeleton. Annu. Rev. Cell Biol. 10: 31-54.
20. Hancock, J.F. 1993. Anti-Ras drugs come of age. Curr. Biol. 3: 770-772.
21. Hancock, J.F., A.I. Magee, J.E. Childs, and C.J. Marshall. 1989. All ras proteins are polyisoprenylated but only some are palmitoylated. Cell 57: 1167-1177.
22. Hancock, J.F., H. Paterson, and C.J. Marshall. 1990. A polybasic domain or palmitoylation is required in addition to the CAAX motif to localize p21ras to the plasma membrane. Cell 63: 133-139.
23. Hancock, J.F., K. Cadwallader, H. Paterson, and C.J. Marshall. 1991. A CAAX or a CAAL motif and a second signal are sufficient for plasma membrane targeting of ras proteins. EMBO J. 10: 4033-4039.
24. James, G.L., J.L. Goldstein, and M.S. Brown. 1995. Polylysine and CVIM sequences of K-RasB dictate specificity of prenylation and confer resistance to benzodiazepine peptidomimetic in vitro. J. Biol Chem. 270: 6221-6226.
25. V12 proteins to farnesyltransferase inhibitors in Rat1 cells. Proc. Natl. Acad. Sci. 93: 4454-4458.
26. Kataoka, T., S. Powers, C. McGill, O. Fasano, J. Strathern, J. Broach, and M. Wigler. 1984. Genetic analysis of yeast RAS1 and RAS2 genes. Cell 37: 437-445.
27. Kawamura, M., K. Kaibuchi, K. Kishi, and Y. Takai. 1993. Translocation of Ki-ras p21 between membrane and cytoplasm by smg GDS. Biochem. Biophys. Res. Commun. 190: 832-841.
28. Khosravi, F.R. and C.J. Der. 1994. The Ras signal transduction pathway. Cancer Metastasis Rev. 13: 67-89.
29. Khosravi, F.R., A.D. Cox, K. Kato, and C.J. Der. 1992. Protein prenylation: Key to ras function and cancer intervention? Cell Growth Differ. 3: 461-469.
30. Kohl, N.E., C.A. Omer, M.W. Conner, N.J. Anthony, J.P. Davide, S.J. deSolms, E.A. Giuliani, R.P. Gomez, S.L. Graham, K. Hamilton et al. 1995. Inhibition of farnesyltransferase induces regression of mammary and salivary carcinomas in ras transgenic mice. Nat. Med. 1: 792-797.
31. Laird, P.W., A. Zijderveld, K. Linders, M.A. Rudnicki, R. Jaenisch, and A. Berns. 1991. Simplified mammalian DNA isolation procedure. Nucleic Acids Res. 19: 4293.
32. Leon, J., I. Guerrero, and A. Pellicer. 1987. Differential expression of the ras gene family in mice. Mol. Cell. Biol. 7: 1535-1540.
33. Lerner, E.C., Y. Qian, A.D. Hamilton, and S.M. Sebti. 1995. Disruption of oncogenic K-Ras4B processing and signaling by a potent geranylgeranyltransferase I inhibitor. J. Biol. Chem. 270: 26770-26773.
34. Macleod, K.F., Y. Hu, and T. Jacks. 1996. Loss of Rb activates both p53-dependent and independent cell death pathways in the developing mouse nervous system. EMBO J. 15: 6178-6188.
35. Mansour, S.L., K.R. Thomas, and M.R. Capecchi. 1988. Disruption of the proto-oncogene int-2 in mouse embryo-derived stem cells: A general strategy for targeting mutations to non-selectable genes. Nature 336: 348-352.
36. Mizuno, T., K. Kaibuchi, T. Yamamoto, M. Kawamura, T. Sakoda, H. Fujioka, Y. Matsuura, and Y. Takai. 1991. A stimulatory GDP/GTP exchange protein for smg p21 is active on the post-translationally processed form of c-Ki-ras p21 and rhoA p21. Proc. Natl. Acad. Sci. 88: 6442-6446.
37. Morgenbesser, S.D., B.O. Williams, T. Jacks, and R.A. DePinho. 1994. p53-dependent apoptosis produced by Rb-deficiency in the developing mouse lens [see comments]. Nature 371: 72-74.
38. Mortensen, R.M., D.A. Conner, S. Chao, L.A. Geisterfer, and J.G. Seidman. 1992. Production of homozygous mutant ES cells with a single targeting construct. Mol. Cell. Biol. 12: 2391-2395.
39. Muller, R., D.J. Slamon, J.M. Tremblay, M.J. Cline, and I.M. Verma. 1982. Differential expression of cellular oncogenes during pre- and postnatal development of the mouse. Nature 299: 640-644.
40. Muller, R., D.J. Slamon, E.D. Adamson, J.M. Tremblay, D. Muller, M.J. Cline, and I.M. Verma. 1983. Transcription of c-onc genes c-rasKi and c-fms during mouse development. Mol. Cell. Biol. 3: 1062-1069.
41. Nakanishi, H., K. Kaibuchi, S. Orita, N. Ueno, and Y. Takai. 1994. Different functions of Smg GDP dissociation stimulator and mammalian counterpart of yeast Cdc25. J. Biol. Chem. 269: 15085-15091.
42. Orita, S., K. Kaibuchi, S. Kuroda, K. Shimizu, H. Nakanishi, and Y. Takai. 1993. Comparison of kinetic properties between two mammalian ras p21 GDP/GTP exchange proteins, ras guanine nucleotide-releasing factor and smg GDP dissociation stimulation. J. Biol. Chem. 268: 25542-25546.
43. Orkin, S.H. 1995. Hematopoiesis: How does it happen? Curr. Opin. Cell Biol. 7: 870-877.
44. Powers, S., T. Kataoka, O. Fasano, M. Goldfarb, J. Strathern, J. Broach, and M. Wigler. 1984. Genes in S. cerevisiae encoding proteins with domains homologous to the mammalian ras proteins. Cell 36: 607-612.
45. Reiss, Y., J.L. Goldstein, M.C. Seabra, P.J. Casey, and M.S. Brown. 1990. Inhibition of purified p21ras farnesyl:protein transferase by Cys-AAX tetrapeptides. Cell 62: 81-88.
46. Shivdasani, R.A., E.L. Mayer, and S.H. Orkin. 1995. Absence of blood formation in mice lacking the T-cell leukaemia oncoprotein tal-1/SCL. Nature 373: 432-434.
47. Till, J.E. and E.A. McCulloch. 1961. A direct measurement of the radiation sensitivity of normal mouse bone marrow cells. Rad. Res. 14: 213-222.
48. Tybulewicz, V.L., C.E. Crawford, P.K. Jackson, R.T. Bronson, and R.C. Mulligan. 1991. Neonatal lethality and lymphopenia in mice with a homozygous disruption of the c-abl protooncogene. Cell 65: 1153-1163.
49. Umanoff, H., W. Edelmann, A. Pellicer, and R. Kucherlapati. 1995. The murine N-ras gene is not essential for growth and development. Proc. Natl. Acad. Sci. 92: 1709-1713.
50. Wassarman, D.A., M. Therrien, and G.M. Rubin. 1995. The Ras signaling pathway in Drosophila. Curr. Opin. Genet. Dev. 5: 44-50.
51. Williams, B.O., E.M. Schmitt, L. Remington, R.T. Bronson, D.M. Albert, R.A. Weinberg, and T. Jacks. 1994. Extensive contribution of Rb-deficient cells to adult chimeric mice with limited histopathological consequences. EMBO J. 13: 4251-4259.
52. Willumsen, B.M., A.G. Papageorge, H.F. Kung, E. Bekesi, T. Robins, M. Johnsen, W.C. Vass, and D.R. Lowy. 1986. Mutational analysis of a ras catalytic domain. Mol. Cell. Biol. 6: 2646-2654.
53. Wittenberg, C. and S.I. Reed. 1996. Plugging it in: Signaling circuits and the yeast cell cycle. Curr. Opin. Cell Biol. 8: 223-230.
54. Wong, P.M., S.W. Chung, D.H. Chui, and C.J. Eaves. 1986. Properties of the earliest clonogenic hemopoietic precursors to appear in the developing murine yolk sac. Proc. Natl. Acad. Sci. 83: 3851-3854.
55. Yamauchi, N., A.A. Kiessling, and G.M. Cooper. 1994. The Ras/ Raf signaling pathway is required for progression of mouse embryos through the two-cell stage. Mol. Cell. Biol. 14: 6655-6662.